Equity Research, Broker Reports, and media content on Diurnal Group

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Diurnal Group
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Diurnal Group. We currently have 67 research reports from 4 professional analysts.

Open
N/A
Range Today
N/A
52 Week
21.3/46.1p
Daily Volume
N/A
# Shares
86.5m
Daily Liquidity
(0.01%)
Pension Liability
£0m
Enterprise Value
£15.9m
Market Cap
£25.5m
Latest PE (hist)
Div Yield
Date Source Announcement
02Dec19 14:28 RNS Share Option Exercise and Issue of Equity
02Dec19 07:01 RNS Holding(s) in Company
02Dec19 07:00 RNS Alkindi New Drug Application Submitted to US FDA
26Nov19 10:42 RNS Director Dealings and Issue of Equity
26Nov19 07:15 EQS Hardman & Co Research: Diurnal (DNL): Successful DITEST Phase I trial outcome
21Nov19 13:08 RNS Results of Annual General Meeting
21Nov19 07:00 RNS AGM Statement
  • Frequency of research reports

     

  • Research reports on

    Diurnal Group

  • Providers covering

    Diurnal Group